AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes
Clinical & Experimental Allergy · 2026
DOI: 10.1111/cea.70234 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, 2026. Verfasst von Jakub Zydron und 13 weiteren Autor:innen. Beteiligte Einrichtung: St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Ho…. Hauptthemen laut MEDLINE: Neoplasms, Hypersensitivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRUK City of London Centre, King's Health Partners Centre for Translational Medicine, Luxembourg National Research Fund (FNR) and Fondation Cancer Luxembourg.
Abstract (Originalsprache)
The AllergoOncology field brings together the study of allergic and cancer immune responses, having evolved from early epidemiological studies that reported inverse associations between allergies, IgE and cancer risk. Insights from studying allergic inflammation are revealing previously unappreciated immune mechanisms that confer protective effects against cancer, and evasion pathways that facilitate tumour progression. AllergoOncology sheds light on cancers with poor prognosis, including glioma, where evidence has pointed to allergic triggers that may influence glioma biology through rewiring immune surveillance. Allergic signals point to new biomarkers that may identify groups at higher risk of developing cancer, aid patient stratification and help monitor treatment and clinical outcomes. Allergic mediators such as histamine and IgE levels are emerging biomarkers that can inform cancer risk and lead to clinical interventions that improve outcomes. Emerging cancer immunotherapies, such as tumour antigen‐specific IgEs, an evolving therapy class, are and will continue to be inspired by understanding allergic immune response mechanisms. Assays, including the Basophil Activation Test developed for monitoring and managing allergic reactions, are translated to the oncology clinic to evaluate hypersensitivity to anti‐cancer therapeutics. Allergy research brings fundamental benefits for oncology through understanding and harnessing allergic and cancer‐associated mechanisms in AllergoOncology for patient benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, UK.
- School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
- Randall Centre for Cell and Molecular Biophysics, School of Basic and Medical Biosciences, King's College London, London, UK.
- Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.
- Ludger Ltd., Culham Campus, Abingdon, Oxfordshire, UK.
- Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, King's College London, London, UK.
ORCID-Profile: Jitesh Chauhan, James McDonnell
Förderung
- CRUK City of London Centre
- King's Health Partners Centre for Translational Medicine
- Luxembourg National Research Fund (FNR) and Fondation Cancer Luxembourg
- Télévie-FNRS
- Worldwide Cancer Research
- Medical Research Council
- Breast Cancer Now
Zitieren
APA
Zydron, J., Balaji, A., Chauhan, J., Alder, J., Chen, X., Wiegman, A. M. F., Poli, A., Jacków-Malinowska, J., Cheeseman, J., Spencer, D. I. R., McDonnell, J., Spicer, J., McCraw, A. J., & Karagiannis, S. N. (2026). AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70234
Vancouver
Zydron J, Balaji A, Chauhan J, Alder J, Chen X, Wiegman AMF, et al. AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70234
BibTeX
@article{Zydron2026,
author = {Zydron, Jakub and Balaji, Anishaa and Chauhan, Jitesh and Alder, Jack and Chen, Xinyi and Wiegman, Anna M F and Poli, Aurelie and Jacków-Malinowska, Joanna and Cheeseman, Jack and Spencer, Daniel I R and McDonnell, James and Spicer, James and McCraw, Alexandra J and Karagiannis, Sophia N},
title = {AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes},
journal = {Clinical & Experimental Allergy},
year = {2026},
doi = {10.1111/cea.70234}
}
EUVIMED